Dr. Tomoko Quinn

Headache specialist · Hospital Sírio-Libanês · Brazil (BR) · Neurology

Tier 1STK-0109GoodOwner MSL LOLuis Ortega

Data minimisation

Consent status: Recorded. The name shown may be a pseudonym. Contact details, personal identifiers and remuneration fields are hidden for your role; only scientific-profile fields needed for engagement planning are displayed.

Specialty: Headache medicine
Disease interests: MIG
Scientific interests: Medication-overuse headacheCGRP persistence
Engagement preference: Virtual
Advisory boards: 2
Publications: 52
Source system: Manual
Data quality: Good

Engagement plan

Cadence target for Tier 1: 4 per year (assumption)

Last engaged: 02 May 2026 (136 days ago)
Next planned contact: 01 Aug 2026 Overdue
Last 6 months vs target: 50%
1 of 2 expected engagements

Insights from this stakeholder (3)

INS-0019Chronic migraine data
02 May 2026 · Adherence and persistence
HighAction in progress
INS-0057Switching between CGRP agents
02 Mar 2026 · Adherence and persistence
MediumArchived
INS-0034Dosing in hepatic impairment
14 Feb 2026 · Clinical practice
HighDeduplicated

Engagement history (3)

All engagements including drafts, newest first

Date	Type	Format	MSL	Product	Topics	Insights	Flags	Status
02 May 2026	Congress meeting	Virtual	Luis Ortega	Lumeva	Chronic migraine data	1	—	Reviewed	ENG-0209
28 Feb 2026	Medical education	In person	Luis Ortega	Lumeva	Switching between CGRP agents	1	—	Reviewed	ENG-0225
12 Feb 2026	Advisory board	Phone	Luis Ortega	Lumeva	Dosing in hepatic impairmentReal-world persistence	1	—	Reviewed	ENG-0203

Timeline

02 May 2026
Congress meeting
Chronic migraine data
28 Feb 2026
Medical education
Switching between CGRP agents
12 Feb 2026
Advisory board
Dosing in hepatic impairment, Real-world persistence

Related stakeholders (2)

Hospital Sírio-Libanês

Dr. Oscar Ueda
General neurologist
Tier 2
Dr. Mariana Lopez
Headache specialist
Tier 1